I
ImageneBio, Inc. (IMA)
NCM – Real Time Price. Currency in USD
5.00
-0.40 (-7.41%)
At close: Mar 27, 2026, 4:00 PM EDT
5.00
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
5.00
-0.40 (-7.41%)
At close: Mar 27, 2026, 4:00 PM EDT
5.00
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 12.49 | 6.05 | 10 | |
| Quick ratio | 12.49 | 5.63 | 10 | |
| Debt to Equity | 0.08 | 0.30 | 9.0 | |
| Debt to Assets | 0.07 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 16M | 9M | 4M | 800K | N/A |
| Gross Profit | 14M | 8M | 2M | -233K | -735K |
| Operating Income | -71M | -75M | -37M | -48M | -53M |
| Net Income | -69M | -68M | -37M | -45M | -43M |
| EBITDA | -69M | -74M | -35M | -47M | -52M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 67.32 | 5.5 |
| Next quarter | 100 | 64.63 | 10 |
| Current year | -100 | 69.61 | 5.5 |
| Next year | N/A | 17.63 | 5.0 |
| Weighted average score | 6.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 72.12 | 78.69 | 72.91 | 10 |
| Y/Y | 999 | -43.55 | 74.17 | -15.29 | 5.5 |
| 3y average | -60.07 | 7.74 | 24.29 | 10.84 | 6.0 |
| 5y average | 1.44 | -11.08 | 21.9 | -9.98 | 3.8 |
| Weighted average score | 6.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $94.5M significantly exceed its total debt $10.0M, ensuring strong financial flexibility
Total current assets $140.3M exceed Total current liabilities $11.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$7.2M limits the company's ability to reinvest or pay down debt